Nasdaq
LIMN
Liminatus Pharma, Inc.
- Health Care
- 1 day
- −5.8%
- 1 month
- −23.6%
- 1 year
- −97.9%
$0.0989 · Mkt cap $6.64M
At the 6 Aug 2026 close
Nasdaq
Liminatus Pharma, Inc.
$0.0989 · Mkt cap $6.64M
At the 6 Aug 2026 close
Liminatus Pharma, Inc. trades under the ticker LIMN on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $6.64M. The last closing price was $0.0989, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −97.9%, and −23.6% over the past month. Returns are price returns and exclude dividends.
This page exists because LIMN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.